Publications by authors named "Anne Bertasso"

Claim this Profile
M
Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study.
Edward J Gane, Paul J Pockros, Stefan Zeuzem, Patrick Marcellin, Anna Shikhman, Anne Bertasso

Liver Int· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device.
Peter Varunok, Eric Lawitz, Kimberly L Beavers, Gary Matusow, Ruby Leong, Anne Bertasso

Patient Prefer Adherence· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial.
Maribel Rodriguez-Torres, Jihad Slim, Laveeza Bhatti, Richard Sterling, Mark Sulkowski, Anne Bertasso

HIV Clin Trials· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to enfuvirtide and its impact on treatment efficacy.
Jürgen Rockstroh, Edwin Dejesus, Lucille Donatacci, Cynthia Wat, Anne Bertasso

AIDS Res Hum Retroviruses· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients.
Andrew Wiznia, Joseph Church, Patricia Emmanuel, Stephen Eppes, Lucy Rowell, Anne Bertasso

Pediatr Infect Dis J· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.
Xiaoping Zhang, Tiffany Lin, Anne Bertasso, Claire Evans, Albert Dorr

J Clin Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.
Benoit Trottier, Sharon Walmsley, Jacques Reynes, Peter Piliero, Mary O'Hearn, Anne Bertasso

J Acquir Immune Defic Syndr· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of enfuvirtide in pediatric human immunodeficiency virus 1-infected patients receiving combination therapy.
S Eralp Bellibas, Zikia Siddique, Albert Dorr, Anne Bertasso, Prakash Sista

Pediatr Infect Dis J· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis